Perpetual Ltd Acquires New Position in Healthpeak Properties, Inc. (NYSE:DOC)

Perpetual Ltd acquired a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 63,060 shares of the real estate investment trust’s stock, valued at approximately $1,442,000.

Other hedge funds also recently made changes to their positions in the company. Pensionfund Sabic bought a new position in shares of Healthpeak Properties during the 3rd quarter valued at approximately $2,556,000. Mirador Capital Partners LP bought a new position in shares of Healthpeak Properties during the 3rd quarter valued at approximately $737,000. Novak & Powell Financial Services Inc. bought a new position in shares of Healthpeak Properties during the 4th quarter valued at approximately $206,000. GAMMA Investing LLC purchased a new position in Healthpeak Properties in the 3rd quarter worth approximately $605,000. Finally, AMF Tjanstepension AB purchased a new position in Healthpeak Properties in the 3rd quarter worth approximately $15,548,000. 93.57% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

DOC has been the topic of a number of research analyst reports. Wells Fargo & Company reissued an “equal weight” rating and issued a $23.00 price target (up from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st. Evercore ISI upped their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a report on Monday, September 16th. StockNews.com raised Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Friday. Wedbush upped their price objective on Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a report on Monday, July 29th. Finally, Citigroup upped their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Six analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $22.17.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $21.67 on Friday. The stock’s fifty day moving average is $22.05 and its 200 day moving average is $20.35. Healthpeak Properties, Inc. has a fifty-two week low of $15.24 and a fifty-two week high of $23.14. The firm has a market capitalization of $15.25 billion, a PE ratio of 61.91, a PEG ratio of 2.27 and a beta of 1.14. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.23). Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. The company had revenue of $695.50 million for the quarter, compared to analysts’ expectations of $665.11 million. During the same quarter in the previous year, the company posted $0.45 EPS. The business’s quarterly revenue was up 27.5% on a year-over-year basis. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Shareholders of record on Monday, August 5th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 5.54%. The ex-dividend date of this dividend was Monday, August 5th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 342.86%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.